Value of endometrial biopsy in patients with hysteroscopically atrophic endometrium in patients with postmenopausal bleeding
Archives of Gynecology and Obstetrics · 2025
DOI: 10.1007/s00404-024-07922-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2025. Verfasst von Ayisha A Ashmore und 9 weiteren Autor:innen. Beteiligte Einrichtung: Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hosp…. Hauptthemen laut MEDLINE: Endometrium, Endometrial Neoplasms, Uterine Hemorrhage, Precancerous Conditions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To determine the rate of precancer and cancer in women presenting with PMB who have a visually atrophic endometrium at hysteroscopy and assess the value of endometrial biopsy in this situation and the adequacy of the samples obtained.
Methods
Retrospective reviews of all patients with a visually atrophic endometrium at hysteroscopy who had presented with PMB and had an ET > / = 4 mm or ET < 4 mm with focal changes or irregular features between 2013 and 2024 at University Hospitals of Derby and Burton were included ( n = 1096). Patients who had previously had cancer or precancer or had unclear hysteroscopy findings were excluded. The endometrial biopsy histology result was considered the main outcome measure.
Results
188 patients did not have a biopsy performed (17.15%), 660 patients had benign pathology (60.22%), and 239 patients had an inadequate sample result (21.81%). Nine patients had precancerous changes (0.82%). The rate of cancer was 0.00% ( n = 0). The NPV of a visually atrophic endometrial cavity at hysteroscopy in detecting precancer or cancer was 99.2%. Patients with an ET < 4 mm pre-hysteroscopy and an atrophic endometrial cavity at hysteroscopy were 2.25 times more likely than those whose ET is > 4 mm to have an inadequate sample ( p < 0.001, 95% CI 1.61–3.16). 10 patients who had an inadequate sample at initial biopsy had a repeat inadequate sample ( n = 23, 43.48%).
Conclusions
The incidence of precancer/cancer in patients presenting with PMB with a visually atrophic endometrium at hysteroscopy is low. Many patients within this cohort have an inadequate sample at biopsy, and therefore, repeat sampling is of questionable value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK. ayisha.ashmore1@nhs.net.
- Derby Gynaecological Cancer Centre, Department of Gynaecology, University Hospitals of Derby and Burton NHS Foundation Trust (UHDB), Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK.
- University of Nottingham, Nottingham, UK.
ORCID-Profile: Ayisha A Ashmore
Zitieren
APA
Ashmore, A. A., Alao, A. I., Hibbard, A., Burchnall, L., Menic, N., Abdul, S., Asher, V., Bali, A., Kolhe, S., & Phillips, A. (2025). Value of endometrial biopsy in patients with hysteroscopically atrophic endometrium in patients with postmenopausal bleeding. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07922-3
Vancouver
Ashmore AA, Alao AI, Hibbard A, Burchnall L, Menic N, Abdul S, et al. Value of endometrial biopsy in patients with hysteroscopically atrophic endometrium in patients with postmenopausal bleeding. Archives of Gynecology and Obstetrics. 2025. doi:10.1007/s00404-024-07922-3
BibTeX
@article{Ashmore2025,
author = {Ashmore, Ayisha A and Alao, Abayomi I and Hibbard, Amie and Burchnall, Libbi and Menic, Natalie and Abdul, Summi and Asher, Viren and Bali, Anish and Kolhe, Shilpa and Phillips, Andrew},
title = {Value of endometrial biopsy in patients with hysteroscopically atrophic endometrium in patients with postmenopausal bleeding},
journal = {Archives of Gynecology and Obstetrics},
year = {2025},
doi = {10.1007/s00404-024-07922-3}
}
EUVIMED